Drug maker halts early human trial of new compound
NCT ID NCT06579300
Summary
This early-stage study aimed to check the safety of a new drug called ABBV-1088 and see how the body absorbs and processes it. It involved 72 healthy adults from Western, Chinese, and Japanese backgrounds. The study also looked at how the drug might interact with another common medication. The trial has been terminated.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Acpru /Id# 270552
Grayslake, Illinois, 60030, United States
-
CenExel ACT- Anaheim Clinical Trials /ID# 276423
Anaheim, California, 92801, United States
Conditions
Explore the condition pages connected to this study.